Concepedia

Shashank Rohatagi

SR

Statistics

Publications

54

Citations

2.4K

H-Index

29

Active since

1995

Affiliations

Daiichi Sankyo (United States)(Current)

University of Florida

Somerset Medical Center

Sanofi (United States)

Florida College

Shashank Rohatagi is an author at Daiichi Sankyo (United States) specializing in pharmacology, pharmacy, and pharmacokinetics.

Publications per year

1995–2016

54

Publications

54

Randomised, parallel-group, multicentre, multinational phase 2 study comparing edoxaban, an oral factor Xa inhibitor, with warfarin for stroke prevention in patients with atrial fibrillation

Stuart J. Connolly, Indravadan Patel, Daniel E. Salazar et al. · Thrombosis and Haemostasis · 2010 · 343 citations

, , +12

Modelling and simulation of edoxaban exposure and response relationships in patients with atrial fibrillation

Jeanne Mendell, Helen Kastrissios, Michelle Green et al. · Thrombosis and Haemostasis · 2012 · 150 citations

, , +17

Pharmacokinetics of Triamcinolone Acetonide After Intravenous, Oral, and Inhaled Administration

Hartmut Derendorf, Günther Hochhaus, Shashank Rohatagi et al. · The Journal of Clinical Pharmacology · 1995 · 112 citations

, , +8

Population Pharmacokinetics and Pharmacodynamics of Ciclesonide

Shashank Rohatagi, Vikram Arya, Karl Zech et al. · The Journal of Clinical Pharmacology · 2003 · 105 citations

, , +17

Ciclesonide, a Novel Inhaled Steroid, Does Not Affect Hypothalamic-Pituitary-Adrenal Axis Function in Patients With Moderate-to-Severe Persistent Asthma

Stanley J. Szefler, Shashank Rohatagi, J. E. Williams et al. · CHEST Journal · 2005 · 91 citations

, , +16

1–5 of 54